Company: Incyte CorporationBloomberg ticker: INCY USMarket cap: US$16,227mBackground: Incyte Corporation, a U.S.-based biopharmaceutical company, focuses on the discovery, development, and commercialization of therapeutics. It operates globally, specializing in oncology and inflammation. Its key products include Jakafi (ruxolitinib), a treatment for certain blood cancers, and Opzelura, a cream for dermatological conditions.World Class Benchmarking of Incyte Corp Profitable Growth rank of 1 was up compared t ...